Patent Assignment
Reel/Frame 045450/0503
Security Interest
Recorded: 2018-02-27
Pages: 26
Assignors
CAPITAL ROYALTY PARTNERS II L.P.
Executed: 2018-02-23
CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.
Executed: 2018-02-23
PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Executed: 2018-02-23
Assignee
BIODESIX, INC.
2970 WILDERNESS PLACE, SUITE 100, BOULDER, COLORADO, 80301
Covered Properties
(38)
Deep-Maldi Tof Mass Spectrometry of Complex Biological Samples, E.G., Serum, and Uses Thereof
PCT:
PCT/US2013/031998 ↗
Method for Predicting Whether a Cancer Patient Will Not Benefit from Platinum-Based Chemotherapy Agents
PCT:
PCT/US2013/032010 ↗
Mass-Spectral Method for Selection, and De-Selection, of Cancer Patients for Treatment with Immune Response Generating Therapies
PCT:
PCT/US2013/032024 ↗
Method to automatically identify peak and monoisotopic peaks in mass spectral data for biomolecular applications
Application:
10/887,138 →
Publication:
US 2005/0267689
Interactive system for performing automated protein identification from mass spectrometry data
Application:
10/887,496 →
Publication:
US 2005/0060652
Method and System for Determining Whether a Drug Will Be Effective on a Patient with a Disease
Method for Reliable Classification of Samples in Clinical Diagnostics Using an Improved Method of Classification
Selection of Non-Small-Cell Lung Cancer Patients for Treatment with Monoclonal Antibody Drugs Targeting Egfr Pathway
Selection of Head and Neck Cancer Patients for Treatment with Drugs Targeting Egfr Pathway
Selection of Colorectal Cancer Patients for Treatment with Drugs Targeting Egfr Pathway
Monitoring Treatment of Cancer Patients with Drugs Targeting Egfr Pathway Using Mass Spectrometry of Patient Samples
Method and System for Determining Whether a Drug Will Be Effective on a Patient with a Disease
Method and System for Determining Whether a Drug Will Be Effective on a Patient with a Disease
Method and System for Determining Whether a Drug Will Be Effective on a Patient with a Disease
Monitoring treatment of cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
Application:
12/931,321 →
Publication:
US 2011/0121167
Monitoring Treatment of Head and Neck Cancer Patients with Drugs Egfr Pathway Using Mass Spectrometry of Patient Samples
Monitoring Treatment of Colorectal Cancer Patients with Drugs Targeting Egfr Pathway Using Mass Spectrometry of Patient Samples
Cancer patient selection for administration of therapeutic agents using mass spectral analysis of blood-based samples
Application:
12/932,295 →
Publication:
US 2011/0208433
Method to automatically identify peaks and monoisotopic peaks in mass spectral data for biomolecular applications
Application:
13/136,113 →
Publication:
US 2011/0282588
Monitoring treatment of colorectal cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
Monitoring treatment of Head and Neck cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
A Method for Predicting Breast Cancer Patient Response to Endocrine Therapy
Method and system for determining whether a drug will be effective on a patient with a disease
Method and system for determining whether a drug will be effective on a patient with a disease
Application:
13/434,132 →
Publication:
US 2012/0191370
Method and System for Validation of Mass Spectrometer Machine Performance
Patent:
8,467,988 →
Application:
13/733,018 →
A Method for Predicting Breast Cancer Patient Response to Combination Therapy
Mass-Spectral Method for Selection, and De-Selection, of Cancer Patients for Treatment with Immune Response Generating Therapies
Method for predicting whether a cancer patient will not benefit from platinum-based chemotherapy agents
Deep-MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof
Method to automatically identify peak and monoisotopic peaks in mass spectral data for biomolecular applications
Application:
60/485,632 →
Method for reliable classification of samples in clinical diagnostic using an improved method for classification
Application:
60/959,990 →
Cancer patient selection for administration of therapeutic agents using mass spectral analysis of blood-based samples
Application:
61/338,938 →
Predictive test for selection of metastatic breast cancer patients for combination therapy
Application:
61/437,575 →
Multi-shot MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof
Application:
61/652,394 →
Mass-Spectral Method for Selection, and De-selection, of Cancer Patients for Treatment with Immune Response Generating Therapies
Application:
61/664,308 →
Mass-Spectral Method for Selection, and De-Selection, of Cancer Patients for Treatment with Immune Response Generating Therapies
Application:
61/664,329 →
Method for predicting whether a cancer patient will not benefit from platinum-based chemotherapy agents
Application:
61/668,077 →
Classification method using combination of mini-classifiers with dropout and uses thereof
Application:
61/878,110 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 23, 2004
From: CHAZIN, DAVID
To: EFECKTA TECHNOLOGIES CORPORATION
Reel/Frame 016023/0385 →
Assignment of Assignor's Interest
Dec 20, 2004
From: TSYPIN, MAXIM
To: EFECKTA TECHNOLOGIES CORPORATION
Reel/Frame 016085/0579 →
Assignment of Assignor's Interest
Mar 16, 2007
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC., A DELAWARE CORPORATION
Reel/Frame 019021/0827 →
Assignment of Assignor's Interest
Aug 12, 2008
From: TSYPIN, MAXIM; ROEDER, HEINRICH
To: BIODESIX, INC.
Reel/Frame 021388/0135 →
Assignment of Assignor's Interest
Oct 14, 2008
From: EFECKTA TECHNOLOGIES CORPORATION, A DELAWARE CORPORATION
To: ELSTON TECHNOLOGIES, INC., A DELAWARE CORPORATION
Reel/Frame 021802/0134 →
Change of Name
Nov 13, 2008
From: ELSTON TECHNOLOGIES, INC., A DELAWARE CORPORATION
To: BIODESIX, INC., A DELAWARE CORPORATION
Reel/Frame 021833/0666 →
Assignment of Assignor's Interest
Mar 2, 2009
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 022348/0989 →
Assignment of Assignor's Interest
Mar 2, 2009
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 022349/0058 →
Assignment of Assignor's Interest
Mar 2, 2009
From: ROEDER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 022348/0985 →
Assignment of Assignor's Interest
Sep 28, 2009
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 023301/0428 →
Assignment of Assignor's Interest
Nov 9, 2009
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 023509/0816 →
Assignment of Assignor's Interest
Mar 29, 2011
From: RODER, HEINRICH
To: BIODESIX, INC.
Reel/Frame 026040/0494 →
Assignment of Assignor's Interest
Apr 12, 2011
From: GRIGORIEVA, JULIA; TSYPIN, MAXIM
To: BIODESIX, INC.
Reel/Frame 026172/0229 →
Short-Form Patent Security Agreement
Dec 3, 2013
From: BIODESIX, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031751/0694 →
Assignment of Assignor's Interest
Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044813/0947 →
Assignment of Assignor's Interest
Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044815/0024 →
Assignment of Assignor's Interest
Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044815/0155 →
Assignment of Assignor's Interest
Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044816/0809 →
Assignment of Assignor's Interest
Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044817/0347 →
Assignment of Assignor's Interest
Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044817/0429 →
Assignment of Assignor's Interest
Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044817/0564 →
Assignment of Assignor's Interest
Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044818/0967 →
Assignment of Assignor's Interest
Feb 5, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044831/0054 →
Assignment of Assignor's Interest
Feb 5, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044831/0038 →
Assignment of Assignor's Interest
Feb 5, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044831/0024 →